Corbevax: "A milestone for global vaccine equity"
this is an opinion piece in Scientific American 12/30/21 by Peter Hotez and Maria Bottazzi
While the Omicron variant spreads across the world and major producers of COVID vaccines squabble over granting global access, a vaccine developed by the Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD) and Baylor College of Medicine is ready to be deployed. In the last week of 2021, India’s drug regulation agency authorized a vaccine producer in the country to begin distributing a COVID vaccine called CORBEVAX.
Two years into the pandemic, CORBEVAX is the first COVID vaccine designed specifically for global health. It is a milestone for global vaccine equity, something we believe will overcome vaccine hesitancy, and serves as a blueprint for how to develop a potent vaccine for pandemic use in the absence of substantial public funding.
The vaccine prototype was first developed by scientists at Texas Children’s CVD and Baylor before it was licensed, with no patents or strings attached, to Biological E. Limited (BioE).
The central government of India has already ordered 300 million doses. And BioE, the company manufacturing the vaccine, plans to produce 100 million or more doses per month starting in February. Approximately 150 million doses have already been produced and are ready to roll out. In addition to what the company is supplying to India, BioE plans to deliver more than one billion additional doses to other countries.
https://www.scientificamerican.com/article/a-covid-vaccine-for-all/
This is big, but, oh no! It might hurt the mega-pharma profits!!
= new reply since forum marked as read
